Your browser doesn't support javascript.
The RECOVERY trial: cardiovascular implications of a large, simple randomized trial in COVID-19.
Pessoa-Amorim, Guilherme; Mafham, Marion M.
  • Pessoa-Amorim G; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, OX3 7LF, UK.
  • Mafham MM; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, OX3 7LF, UK.
Cardiovasc Res ; 117(9): e110-e113, 2021 07 27.
Article in English | MEDLINE | ID: covidwho-1328916

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Cardiovascular Diseases / Fibrinolytic Agents / COVID-19 / Anti-Inflammatory Agents Type of study: Controlled clinical trial / Diagnostic study / Etiology study / Randomized controlled trials / Risk factors Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: Cardiovasc Res Year: 2021 Document Type: Article Affiliation country: Cvr

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Cardiovascular Diseases / Fibrinolytic Agents / COVID-19 / Anti-Inflammatory Agents Type of study: Controlled clinical trial / Diagnostic study / Etiology study / Randomized controlled trials / Risk factors Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: Cardiovasc Res Year: 2021 Document Type: Article Affiliation country: Cvr